Association between transforming growth factor-beta 1 polymorphism and virologic characteristics of chronic hepatitis C
Received 22 March 2008; received in revised form 2 August 2008; accepted 12 August 2008. published online 10 September 2008.
The production of transforming growth factor beta 1 (TGF-β1) has been reported as being significantly associated with the gene polymorphism in the leader sequence at positions +29. The current study aimed to evaluate the associations between the polymorphism and the clinical characteristics of chronic hepatitis C (CHC). A total of 422 (252 men; mean age: 49.7 ± 11.2 years) Taiwanese CHC patients with liver biopsies were enrolled. The TGF-β1 gene polymorphism at position +29 (T or C), hepatitis C virus (HCV) RNA genotypes, and serum HCV RNA levels of these patients were determined. Of the 422 patients, the frequency of the T allele was 45.4%. Based on univariate analyses, a significantly lesser proportion of patients with allele T had high viral loads than those who were without allele T (P = 0.026). The lesser HCV RNA levels and HCV genotype 1b infection were significantly associated with the inheritance of the T allele in female patients based on univariate (P = 0.012 and 0.007, respectively) and multivariate regression (odds ratio/95% confidence interval: 0.434/0.219–0.859 and 0.468/0.237–0.927, respectively) analyses. In male patients with or without inheritance of the T allele, the clinical characteristics were similar. In conclusion, the association between TGF-β1 polymorphism and virologic characteristics of chronic HCV infection implicated a significant role of host genetic factors on the clinical features of CHC. Female patients who carry T allele at position +29 were predisposed to be associated with HCV genotype non-1b infection and lesser HCV viral load, which revealed the gender effect.
aHepatobiliary Division, Department of Internal Medicine, the Department of Occupational and Environmental Medicine, and the Faculty of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
bCollege of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
cDepartment of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
dDepartment of Internal Medicine, Tian-Sheng Memorial Hospital, Pintong, Taiwan
Reprint requests: Ming-Lung Yu, MD, Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, No. 100, Tz-You 1st Rd, Kaohsiung 807, Taiwan
Supported by National Science Council Grant NSC- 93-2314-B037-076 and the Taiwan Liver Research Foundation.